Re: Rituximab maintenance for the treatment of patients with follicular lymphoma: Systematic review and meta-analysis of randomized trials

Journal of the National Cancer Institute

Volumn 101, Issue 18, 2009, Pages 1288-1289

  Tuccori, Marco ^a,b   Focosi, Daniele ^a   Blandizzi, Corrado ^a,b   Del Tacca, Mario ^a,b   Petrini, Mario ^a  

^a UNIVERSITY OF PISA   (Italy)

^b Tuscan Regional Centre of Pharmacovigilance   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RITUXIMAB; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY;

CANCER CHEMOTHERAPY; CANCER INCIDENCE; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG INDICATION; FOLLICULAR LYMPHOMA; FOLLOW UP; HIGH RISK POPULATION; HUMAN; LETTER; MEDICAL RECORD REVIEW; META ANALYSIS; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SYSTEMATIC REVIEW; TREATMENT DURATION; CHEMICALLY INDUCED DISORDER; INCIDENCE; NOTE; RANDOMIZED CONTROLLED TRIAL;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; HUMANS; INCIDENCE; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; LYMPHOMA, FOLLICULAR; META-ANALYSIS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 70349251630     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djp256     Document Type: Letter

References (8)

1. Vidal L, Gafter-Gvili A, Leibovici L, et al. Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials. J Natl Cancer Inst. 2009 ; 101 ( 4 ): 248-255.
2. Carson KR, Evens AM, Richley E, et al. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood. 2009 ; 113 ( 20 ): 4834-4840.
3. Holman RC, Török TJ, Belay ED, Janssen RS, Schonberger LB. Progressive multifocal leukoencephalopathy in the United States, 1979-1994: increased mortality associated with HIV infection. Neuroepidemiology. 1998 ; 17 ( 6 ): 303-309.
4. Bower JH, Hammack JE, McDonnell SK, Tefferi A. The neurologic complications of B-cell chronic lymphocytic leukemia. Neurology. 1997 ; 48 ( 2 ): 407-412.
5. van Rijswijk RE, Verbeek J, Haanen C, et al. Major complications and causes of death in patients treated for Hodgkin's disease. J Clin Oncol. 1987 ; 5 ( 10 ): 1624-1633.
6. Engsig FN, Hansen ABE, Omland LH, et al. Incidence, clinical presentation and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study. J Infect Dis. 2009 ; 199 ( 1 ): 77-83.
7. Neff RT, Hurst FP, Falta EM, et al. Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation. Transplantation. 2008 ; 86 ( 10 ): 1474-1478.
8. Yousry TA, Major EO, Ryschkewitsch C, et al. Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy . N Engl J Med. 2006 ; 354 ( 9 ): 924-933.